KCNE2 gene mutation and Brugada syndrome.


Journal

Journal of electrocardiology
ISSN: 1532-8430
Titre abrégé: J Electrocardiol
Pays: United States
ID NLM: 0153605

Informations de publication

Date de publication:
Historique:
received: 15 12 2020
revised: 29 01 2021
accepted: 30 01 2021
pubmed: 25 2 2021
medline: 10 7 2021
entrez: 24 2 2021
Statut: ppublish

Résumé

KCNE2 gene mutations have been associated with atrial fibrillation, long QT syndrome, Brugada syndrome and unexplained sudden cardiac death. Herein, we describe a case of Brugada syndrome carrying an heterozygous variant in the KCNE2 gene [NM_172201.2:c.161 T > C, p.(Met54Thr, M54T)]. Gain of function of the Ito current possibly explains the Brugada ECG phenotype in this case.

Identifiants

pubmed: 33626434
pii: S0022-0736(21)00039-X
doi: 10.1016/j.jelectrocard.2021.01.022
pii:
doi:

Substances chimiques

KCNE2 protein, human 0
Potassium Channels, Voltage-Gated 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-145

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None to declare.

Auteurs

Ioannis Liatakis (I)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Malena P Pantou (MP)

Molecular Immunopathology and Histocompatibility Unit, Division of Genetics, Onassis Cardiac Surgery Center, Athens, Greece.

Polyxeni Gourzi (P)

Molecular Immunopathology and Histocompatibility Unit, Division of Genetics, Onassis Cardiac Surgery Center, Athens, Greece.

George Bazoukis (G)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Panagiotis Mililis (P)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Athanasios Saplaouras (A)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Konstantinos Vlachos (K)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Efstathia Prappa (E)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Dimitrios Degiannis (D)

Molecular Immunopathology and Histocompatibility Unit, Division of Genetics, Onassis Cardiac Surgery Center, Athens, Greece.

Michael Efremidis (M)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece.

Konstantinos P Letsas (KP)

Second Department of Cardiology, Arrhythmia Unit, Evangelismos General Hospital of Athens, Greece. Electronic address: k.letsas@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH